Literature DB >> 8554386

Repression of involucrin gene expression by transcriptional enhancer factor 1 (TEF-1).

H Takahashi1, H Kobayashi, S Matsuo, H Iizuka.   

Abstract

Involucrin is one of the precursor proteins of keratinocyte cornified envelope that is formed beneath the inner surface of the cell membrane during terminal differentiation. Although involucrin is specifically expressed in the upper squamous cells of the epidermis, the precise regulatory mechanism of involucrin gene expression remains unknown. Transcriptional enhancer factor 1 (TEF-1), which binds to SV40 enhancer, is a nuclear protein expressed in various types of cells including keratinocytes. Immunohistochemical study has revealed that TEF-1 protein is highly expressed on the basal cell layer of the epidermis. To examine the possible regulatory mechanism of involucrin gene expression by TEF-1 protein, we analysed involucrin promoter activity of the INV-CAT vector, which was constructed by connecting the 5' upstream region of the involucrin gene (-801 bp upstream from the transcription start site and downstream including the untranslated first exon) to the chloramphenicol acetyltransferase (CAT) reporter gene. The INV-CAT vector was transfected to SV40-transformed human keratinocytes (SVHK). Cotransfection of the TEF-1 expression vector significantly repressed INV-CAT promoter activity in a dose-dependent manner. The repression was also observed by transfection of the GAL4-TEF-1 vector, which was constructed by replacement of the TEF-1 DNA binding domain by the GAL4 activator domain. This suggests that TEF-1-induced repression is due to interference/squelching of a limiting transcriptional intermediary factor that is essential for involucrin expression.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8554386     DOI: 10.1007/bf01105799

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  25 in total

1.  The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein.

Authors:  M Bodner; J L Castrillo; L E Theill; T Deerinck; M Ellisman; M Karin
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

2.  Differences in involucrin immunolabeling within cornified cell envelopes in normal and psoriatic epidermis.

Authors:  A Ishida-Yamamoto; H Iizuka
Journal:  J Invest Dermatol       Date:  1995-03       Impact factor: 8.551

3.  The human 230-kD bullous pemphigoid antigen gene (BPAG1). Exon-intron organization and identification of regulatory tissue specific elements in the promoter region.

Authors:  K Tamai; D Sawamura; H C Do; Y Tamai; K Li; J Uitto
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

4.  Transformation and immortalization of human keratinocytes by SV40.

Authors:  M L Steinberg; V Defendi
Journal:  J Invest Dermatol       Date:  1983-07       Impact factor: 8.551

5.  The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence.

Authors:  I Davidson; J H Xiao; R Rosales; A Staub; P Chambon
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

6.  Tissue-specific and differentiation-appropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotype.

Authors:  J F Crish; J M Howard; T M Zaim; S Murthy; R L Eckert
Journal:  Differentiation       Date:  1993-07       Impact factor: 3.880

Review 7.  Involucrin--structure and role in envelope assembly.

Authors:  R L Eckert; M B Yaffe; J F Crish; S Murthy; E A Rorke; J F Welter
Journal:  J Invest Dermatol       Date:  1993-05       Impact factor: 8.551

8.  Transcription factor AP-2 is tissue-specific in Xenopus and is closely related or identical to keratin transcription factor 1 (KTF-1).

Authors:  A M Snape; R S Winning; T D Sargent
Journal:  Development       Date:  1991-09       Impact factor: 6.868

9.  KTF-1, a transcriptional activator of Xenopus embryonic keratin expression.

Authors:  A M Snape; E A Jonas; T D Sargent
Journal:  Development       Date:  1990-05       Impact factor: 6.868

10.  Characterization of the transcription activation function and the DNA binding domain of transcriptional enhancer factor-1.

Authors:  J J Hwang; P Chambon; I Davidson
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

View more
  4 in total

1.  Interferon-gamma-dependent stimulation of human involucrin gene expression: STAT1 (signal transduction and activators of transcription 1) protein activates involucrin promoter activity.

Authors:  H Takahashi; K Asano; S Nakamura; A Ishida-Yamamoto; H Iizuka
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

2.  Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription.

Authors:  A J Butler; C P Ordahl
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

3.  A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells.

Authors:  Gernot Walko; Samuel Woodhouse; Angela Oliveira Pisco; Emanuel Rognoni; Kifayathullah Liakath-Ali; Beate M Lichtenberger; Ajay Mishra; Stephanie B Telerman; Priyalakshmi Viswanathan; Meike Logtenberg; Lisa M Renz; Giacomo Donati; Sven R Quist; Fiona M Watt
Journal:  Nat Commun       Date:  2017-03-23       Impact factor: 14.919

4.  TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer.

Authors:  J F Knight; C J Shepherd; S Rizzo; D Brewer; S Jhavar; A R Dodson; C S Cooper; R Eeles; A Falconer; G Kovacs; M D Garrett; A R Norman; J Shipley; D L Hudson
Journal:  Br J Cancer       Date:  2008-11-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.